<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03423576</url>
  </required_header>
  <id_info>
    <org_study_id>VEMSE-CF</org_study_id>
    <nct_id>NCT03423576</nct_id>
  </id_info>
  <brief_title>Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF)</brief_title>
  <acronym>VEMSE-CF</acronym>
  <official_title>Effects of a Comprehensive Patient-centered Health Service With a Focus on Psychosocial Services for Patients With Rare Diseases Using Cystic Fibrosis as an Example (Evaluation Eines Ganzheitlichen Patientenzentrierten Versorgungsmodells für Patienten Mit Seltenen Erkrankungen Unter Besonderer Berücksichtigung Der Psychosozialen Versorgung am Beispiel Mukoviszidose)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mukoviszidose Institut gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal Ministry of Health, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuerzburg University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Frankfurt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CF-Center Hamburg-Altona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Ulm</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Association of Lower Saxony (Ärztekammer Niedersachsen), Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mukoviszidose Institut gGmbH</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For the Project VEMSE-CF, a comprehensive patient-centered outpatient health service model
      was developed offering focused interventions in different areas. These included patient
      education, as well as nutritional and exercise counselling. Special emphasis was given to the
      psycho-social services. The implementation was supported by a case manager. The model was
      implemented in three German CF-Centers. For evaluation, Patient data from 13 additional
      German CF-Centers offering standard care was used as comparison. In total, 153 patients in
      the Intervention Group and 163 control patients aged 5-52 years contributed data. The primary
      endpoint was the number of BMI- and FEV1-measurements over 24 months. Secondary endpoints
      included mortality, lung transplantation, FEV1, BMI, adherence to therapy, Quality of life,
      and mental stress.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2011</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">February 28, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking_description>there was no masking of patients or outcome assessors</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of BMI and FEV1 assessments</measure>
    <time_frame>24 months</time_frame>
    <description>crude number of assessments (BMI and FEV1) performed during the study period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>24 months</time_frame>
    <description>Number of patients deceased during the study period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Referrals for Lung Transplantation</measure>
    <time_frame>24 months</time_frame>
    <description>number of patients referred for lung Transplantation during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delta FEV1</measure>
    <time_frame>24 months</time_frame>
    <description>Change in FEV1 from baseline to end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delta BMI</measure>
    <time_frame>24 months</time_frame>
    <description>Change in BMI from baseline to end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outpatient visits</measure>
    <time_frame>24 months</time_frame>
    <description>Number of outpatient visits during study period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalizations</measure>
    <time_frame>24 months</time_frame>
    <description>number of hospitalizations during the study period</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Delta Proportion of patients with subnormal FEV1</measure>
    <time_frame>24 months</time_frame>
    <description>Change in the Proportion of patients with an FEV1&lt;80% predicted</description>
  </other_outcome>
  <other_outcome>
    <measure>Delta Proportion of Patients with well preserved BMI</measure>
    <time_frame>24 months</time_frame>
    <description>Change in the Proportion of patients with a BMI equal or greater 22 kg/m2 (females) or 23 kg/m2 (males)</description>
  </other_outcome>
  <other_outcome>
    <measure>Adherence to therapy</measure>
    <time_frame>24 months</time_frame>
    <description>Performance of planned assessments (four per year; eight during intervention)</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life (patients)</measure>
    <time_frame>24 months</time_frame>
    <description>Self- or proxy-Report of patients´ Quality of Life: questionnaire - EQ5D (adults) / EQ5D - Y (13-18) / CFQ-R-6-12; three assessments during intervention (begin / after 12 month /after 24 month)</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life (parents)</measure>
    <time_frame>24 months</time_frame>
    <description>self-report of parents´ Quality of Life; questionnaire - EY5D; three assessments during intervention(begin / after 12 month /after 24 month)</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotional stress (Patients)</measure>
    <time_frame>24 months</time_frame>
    <description>Self- or proxy-Report of patients´ emotional stress; questionnaire - Hospital Anxiety and Depression Scale (HADS); three assessments during Intervention (begin / after 12 month /after 24 month)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">318</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>comprehensive patient-centered outpatient health service with multiple components. These components included the addition of a case-manager, structured interventions to improve patient education and adherence to therapy, psychological counselling, social services, and exercise advice. For each Patient, relevant components were identified and a written Intervention plan was negotiated and signed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>comprehensive patient-centered outpatient health service with multiple components</intervention_name>
    <description>Individualized multi-component education and counselling program coordinated by a case Manager.</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  confirmed diagnosis of Cystic Fibrosis - written informed consent

          -  intervention group: care in one of the 3 CF-centers

          -  control group: care in one of the 13 control CF-centers

        Exclusion Criteria:

          -  post lung Transplantation

          -  listed for lung Transplantation and planned inpatient stay for more than 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Uta Düesberg, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Mukoviszidose Institut gGmbH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miriam Schlangen, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Mukoviszidose Institut gGmbH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lutz Goldbeck, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ulm University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helge Hebestreit, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wuerzburg University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mukoviszidose Institut</name>
      <address>
        <city>Bonn</city>
        <zip>53117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Besier T, Born A, Henrich G, Hinz A, Quittner AL, Goldbeck L; TIDES Study Group. Anxiety, depression, and life satisfaction in parents caring for children with cystic fibrosis. Pediatr Pulmonol. 2011 Jul;46(7):672-82. doi: 10.1002/ppul.21423. Epub 2011 Mar 7.</citation>
    <PMID>21384564</PMID>
  </reference>
  <reference>
    <citation>Goldbeck L, Besier T, Hinz A, Singer S, Quittner AL; TIDES Group. Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis. Chest. 2010 Oct;138(4):929-36. doi: 10.1378/chest.09-2940. Epub 2010 May 14.</citation>
    <PMID>20472857</PMID>
  </reference>
  <reference>
    <citation>Kerem E, Conway S, Elborn S, Heijerman H; Consensus Committee. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005 Mar;4(1):7-26. Review.</citation>
    <PMID>15752677</PMID>
  </reference>
  <reference>
    <citation>Ravens-Sieberer U, Otto C, Kriston L, Rothenberger A, Döpfner M, Herpertz-Dahlmann B, Barkmann C, Schön G, Hölling H, Schulte-Markwort M, Klasen F; BELLA study group. The longitudinal BELLA study: design, methods and first results on the course of mental health problems. Eur Child Adolesc Psychiatry. 2015 Jun;24(6):651-63. doi: 10.1007/s00787-014-0638-4. Epub 2014 Nov 27.</citation>
    <PMID>25428179</PMID>
  </reference>
  <reference>
    <citation>Ruf K, Winkler B, Hebestreit A, Gruber W, Hebestreit H. Risks associated with exercise testing and sports participation in cystic fibrosis. J Cyst Fibros. 2010 Sep;9(5):339-45. doi: 10.1016/j.jcf.2010.05.006. Epub 2010 Jul 2.</citation>
    <PMID>20584632</PMID>
  </reference>
  <reference>
    <citation>Sens B, Stern M. (2012) (Hrsg).Qualitätssicherung Mukoviszidose. Überblick über den Gesundheitszustand der Patienten in Deutschland 2012, Bonn/Hannover</citation>
  </reference>
  <reference>
    <citation>Graf von der Schulenburg JM, Greiner W, Jost F, Klusen N, Kubin M, Leidl R, Mittendorf T, Rebscher H, Schoeffski O, Vauth C, Volmer T, Wahler S, Wasem J, Weber C; Hanover Consensus Group. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus. Value Health. 2008 Jul-Aug;11(4):539-44. doi: 10.1111/j.1524-4733.2007.00301.x. Epub 2008 Jan 11.</citation>
    <PMID>18194408</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2018</study_first_submitted>
  <study_first_submitted_qc>January 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2018</study_first_posted>
  <last_update_submitted>February 15, 2018</last_update_submitted>
  <last_update_submitted_qc>February 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>health services</keyword>
  <keyword>FEV1</keyword>
  <keyword>BMI</keyword>
  <keyword>quality of life</keyword>
  <keyword>mental stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

